Osteogenesis Imperfecta study: REMS
Official title REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
ClinicalTrials.gov ID: NCT07412782
What this study is testing
- What it's testing
- This study is testing whether REMS (a radiation‑free ultrasound tool) can measure bone mineral density in children with conditions that lower bone health.
- Who it's for
- You may be able to join if you are 5 to 18 years old and have osteoporosis, osteogenesis imperfecta, or another disorder that reduces bone strength.
- What's involved
- You will have a REMS scan of your bones, give a health history, and have height, weight and puberty checks. If you have past DXA scans, those will be used too.
- Time commitment
- The study lasts about 12 months with visits for the REMS scan and related assessments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- Written informed consent from adult patients or parents/legal guardians
- Age between 5 and 18 years
- Both sexes and all ethnicities
- Known condition negatively affecting bone health
You likely can't join if
- \- Age below 5 years or over 18 years
The study team makes the final eligibility decision.
Where it is enrolling
- Florence, Tuscany, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Florence, Tuscany, Italy. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.